SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-042323
Filing Date
2024-10-04
Accepted
2024-10-04 16:56:07
Documents
5
Effectiveness Date
2024-10-04

Document Format Files

Seq Description Document Type Size
1 S-8 a092024s-8.htm S-8 65402
2 EX-FILING FEES ex107calculationoffilingfe.htm EX-FILING FEES 15489
3 EX-5.1 ex51legalopinions-8october.htm EX-5.1 8265
4 EX-23.1 ex_231xpwcconsentoct2024.htm EX-23.1 2369
5 goodwinlogo.jpg GRAPHIC 8245
  Complete submission text file 0001628280-24-042323.txt   103520
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-282513 | Film No.: 241355475
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)